Registered Owners
- View profile →
ERRITA PHARMA
Jl. Peundeuy RT. 04/07 Desa Bojongsalam, Kec. Rancaekek, Jawa Barat, Indonesia
NPWP: 011041811441000
owner
Direktorat Registrasi ObatValid
SUCRALFATE
- BPOM Number
- GKL2506515733A1
- Approved
- 25 June 2026
- Expiry
- 24 May 2031
- Form
- Suspension
About This Registration
SUCRALFATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2506515733A1. Its current registration status is Valid, with the licence valid until 24 May 2031. The product is registered to ERRITA PHARMA and manufactured by ERRITA PHARMA - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration data updated by BPOM
This product's registration details were changed on 1 July 2026. This may reflect a status change, renewal, or correction by BPOM.
Registration Details
- Application
- newaero
- Packaging
- DUS, 1 BOTOL @ 100 ML
- Department
- Direktorat Registrasi Obat
- Data Last Updated
- 1 July 2026
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
ERRITA PHARMA - INDONESIA
KAB. BANDUNG
primary
Ingredients (1)
SUCRALFATE
Market Intelligence
- Owner Portfolio
- ERRITA PHARMA holds 132 BPOM registrations
- Manufacturer Scale
- ERRITA PHARMA - INDONESIA produces 116 registered products
- Registration Age
- Registered for 1 month
- Update Status
- Recently updated (22 days ago)
FDA Cross-Reference
via openFDA- Generic Name
- SUCRALFATE
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- ORAL
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.